Drug Profile
Research programme: GPCR-targeting biotherapeutics - MorphoSys/Heptares Therapeutics Zurich
Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator G7 Therapeutics; MorphoSys
- Developer MorphoSys
- Class Antibodies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified